FEV1改善与COPD急性加重风险降低相关:一项Meta回归分析
该Meta回归分析基于系统综述纳入的COPD试验,探讨FEV1变化与中重度急性加重风险的关系。结果显示,predose FEV1每变化100 mL,HR降低21%,绝对加重率每年每患者减少0.06,RR为0.86,提示气道通畅性改善可能是降低加重风险的机制。
要点
- FEV1每改善100 mL,COPD急性加重HR降低21%。
- FEV1改善与绝对加重率下降及RR降低显著相关。
- 气道通畅性改善可能是减少急性加重的重要机制。
核心结论
- FEV1增加与COPD急性加重风险降低显著相关,提示气道通畅性是重要机制。
研究设计与样本
- 系统综述识别报告predose FEV1变化和中重度急性加重发生的COPD试验,采用Meta回归分析。
- RD和RR分析纳入119,227例患者,HR分析纳入73,475例患者。
主要发现
- predose FEV1每变化100 mL,HR降低21%(95% CI 17-26;P < .001;R2 = 0.85)。
- predose FEV1每变化100 mL,绝对加重率每年每患者减少0.06(95% CI 0.02-0.11;P = .009;R2 = 0.05)。
- predose FEV1每变化100 mL,对应RR为0.86(95% CI 0.81-0.91;P < .001;R2 = 0.20)。
- 该关系在多个亚组分析中保持统计学显著。
临床怎么用
- 临床可关注FEV1改善作为COPD急性加重风险降低的替代指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The mechanism by which various classes of medication reduce COPD exacerbation risk remains unknown. We hypothesized a correlation between reduced exacerbation risk and improvement in airway patency as measured according to FEV1. METHODS: By systematic review, COPD trials were identified that reported therapeutic changes in predose FEV1 (dFEV1) and occurrence of moderate to severe exacerbations. Using meta-regression analysis, a model was generated with dFEV1 as the moderator variable and the absolute difference in exacerbation rate (RD), ratio of exacerbation rates (RRs), or hazard ratio (HR) as dependent variables. RESULTS: The analysis of RD and RR included 119,227 patients, and the HR analysis included 73,475 patients. For every 100-mL change in predose FEV1, the HR decreased by 21% (95% CI, 17-26; P < .001; R2 = 0.85) and the absolute exacerbation rate decreased by 0.06 per patient per year (95% CI, 0.02-0.11; P = .009; R2 = 0.05), which corresponded to an RR of 0.86 (95% CI, 0.81-0.91; P < .001; R2 = 0.20). The relationship with exacerbation risk remained statistically significant across multiple subgroup analyses. CONCLUSIONS: A significant correlation between increased FEV1 and lower COPD exacerbation risk suggests that airway patency is an important mechanism responsible for this effect.
引用
- Zider AD, Wang X, Buhr RG, et al. Reduced COPD Exacerbation Risk Correlates With Improved FEV1: A Meta-Regression Analysis. Chest. 2017. PMID: 28483609. doi:10.1016/j.chest.2017.04.174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。